1 / 6

Automated Insulin Delivery Systems Market to make huge impact in near future basic influencing factors driving the indus

Automated Insulin Delivery Systems Market was valued at USD 4.91 billion in 2019 and is expected to reach USD 7.81 billion by the year 2027 at a CAGR of 6.0%.

marycyrus
Download Presentation

Automated Insulin Delivery Systems Market to make huge impact in near future basic influencing factors driving the indus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Automated Insulin Delivery Systems Market To Reach USD 7.81 Billion By 2027 www.reportsanddata.com

  2. Market Summary Automated Insulin Delivery Systems Market Size – USD 4.91 Billion in 2019, Market Growth - CAGR of 6.0%, Market Trends– Technological advancements and rising demand for user friendly point of care insulin delivery system The Global Automated Insulin Delivery Systems Market was valued at USD 4.91 billion in 2019 and is expected to reach USD 7.81 billion by the year 2027 at a CAGR of 6.0%. The Automated Insulin Delivery Systems (AID) market is majorly driven due to the increasing prevalence of diabetes across the globe. • Further key findings from the report suggest • To capture significant clientele, companies are engaged in developing advanced automated products with enhanced efficiency and ease of use. For instance, in June 2020, Medtronic received the CE-Mark for its MiniMed 780G. The device automatically adjust basal insulin rates after every five minutes and is suitable for diabetic of 7- 80 year old • Expansion of application range of products to address larger set of customers is another strategic initiative to enhance the business target which is likely to promote sales of AID products. For instance, in October 2019, Novo Nordisk received the U.S. Food and Drug Administration (FDA) approval for the expanded application of its Fiasp as insulin infusion pumps in adults with type 1 or type 2 diabetes as an improvement of glycemic control • Rising diabetic population globally, many companies are investing to develop advanced technology. For instance, in February 2020, Becton, Dickinson and Company completed a clinical trial of its BD Libertas a wearable injectors www.reportsanddata.com

  3. MarketSummary Key Players: Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Biocon, Ypsomed, Wockhardt, Digital Medics, Abbott, Companion Medical, F. Hoffmann-La Roche, Ltd., BD, Animas LLC, Medtronic., Tandem Diabetes Care, Inc, Diabetes Care, BIGFOOT BIOMEDICAL, INC, DreaMed Diabetes, Ltd, others Segmentation: • Applications Outlook (Revenue in Million USD; 2017–2027)                   • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus • End Use outlook (Revenue in Million USD; 2017–2027)               • Homecare • Hospitals • Clinics • Others • Product Type Outlook (Revenue in Million USD; 2017–2027) • Devices • Software & Mobile App • Others www.reportsanddata.com Ask for Sample Report at: https://www.reportsanddata.com/sample-enquiry-form/3453

  4. MarketSummary • Regional Outlook (Revenue, USD Billion; 2017-2027) • North America • U.S • Europe • U.K • France • Asia Pacific • China • Japan • South Korea • MEA • Latin America • Brazil • Read More News about Automated Insulin Delivery Systems Market report by Reports and Data: • Automated Insulin Delivery Systems Market: https://www.prnewswire.com/news-releases/automated-insulin-delivery-systems-market-to-reach-usd-7-81-billion-by-2027--reports-and-data-301117775.html • Automated Insulin Delivery Systems Market: http://www.digitaljournal.com/pr/4827722 www.reportsanddata.com Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3453

  5. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  6. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com www.reportsanddata.com

More Related